Navigation Links
Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
Date:4/9/2008

tCGM System), the failure of future development and preliminary marketing efforts related to Echo's tCGM systems, risks and uncertainties relating to Echo's ability to develop, market and sell diagnostic products based on its skin permeation platform technologies, including the Prelude SkinPrep System, the availability of substantial additional equity or debt capital to support its robust research, development and product commercialization activities, and the success of its research, development, and regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to its tCGM systems. Furthermore, Echo's tCGM systems have not yet been approved for sale. The regulatory approval process for its tCGM systems involves, among other things, successfully completing pilot and pivotal clinical trials and obtaining a premarket approval, or PMA, from the FDA. The PMA process requires Echo to prove the safety and efficacy of its tCGM systems to the FDA's satisfaction. This process can be expensive and uncertain, and there is no guarantee that Echo will be able to submit a PMA for its Symphony tCGM System or that its Symphony tCGM System will be approved by the FDA in any specific timeframe or at all. In addition, clinical testing of Echo's products and eventual commercialization of its products are subject to all of the risks and uncertainties set forth in its periodic reports filed with the Securities and Exchange Commission.

These and other factors are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-KSB for the year ended December 31, 2007, its quarterly reports on Form 10-Q, and its current reports on Form 8-K. The foregoing list of factors is not exhaustive. Echo Therapeutics, Inc. undertakes no obligation to publicly update or revise any forward-looking statements.

(C) 2002 - 2008 Echo Ther
'/>"/>

SOURCE Echo Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 /PRNewswire-iReach/ -- MHG Medical ... has launched its Medical Equipment and X-ray ... services are tailored to the cruise industry,s unique ... industry operators to propose that they should develop ... new program is intended to create standardized processes ...
(Date:7/29/2014)... July 29, 2014  Instrumentation Laboratory (IL) today announced the ... corporate logo. This is part of a comprehensive rebranding effort ... in Boston, MA , in 1959, IL ... since 1992.  Other companies in the group include Inova Diagnostics ... ( Barcelona, Spain ).  Like IL, these three ...
(Date:7/29/2014)... Cynosure, Inc. (Nasdaq: ... aesthetic treatment systems for high-volume applications, today reported financial ... Second-quarter 2014 financial results incorporate the acquisition of Palomar ... Second-Quarter 2014 Financial Highlights ... million , Non-GAAP net income of $7.1 million, ...
Breaking Medicine Technology:MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12
... PHILADELPHIA, November 10 , ... of Excellence in Serving,Healthcare Needs of Patients in California, ... Elsevier ( http://www.elsevier.com ), a world leader ... that Trinity Health,( http://www.trinity-health.org ), the nation,s fourth largest ...
... SAN DIEGO, Nov. 9 Volcano Corporation (Nasdaq: ... sales of products for the diagnosis and treatment of ... will be participating in the Third Annual Canaccord Cardiovascular ... Scott Huennekens, president and chief executive officer, will begin ...
Cached Medicine Technology:Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 2Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 3Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 4Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2
(Date:7/29/2014)... discovered a group of new materials capable of ... award worth a combined 2m to find out ... lead to a significant reduction in hospital infections ... health care of hospital patients across the globe. ... the School of Pharmacy and Paul Williams, Professor ...
(Date:7/29/2014)... 2014 CHI-California Healthcare Institute today unveiled ... hepatitis C (hep C) epidemic in the U.S., the ... to reduce human suffering. The report examines key data ... hep C, while highlighting the significance of breakthroughs that ... CHI is a nonprofit, public policy research organization, representing ...
(Date:7/29/2014)... Salt Lake City, UT (PRWEB) July 29, 2014 ... about how Activz produce powders can help parents add ... Magazine article “Little Bites – Key market drivers ... Activz Whole-Food Nutrition, is pleased to announce the ... nutritional benefits of adding the Activz organic vegetable and ...
(Date:7/29/2014)... Researchers at Cold Spring Harbor Laboratory (CSHL) have discovered a ... p53, this protein has been called "the guardian of the ... sense damage to their DNA caused by stress, such as ... UV rays. If the damage is severe, p53 can ... Mutant versions of p53 that no longer perform this vital ...
(Date:7/29/2014)... July 29, 2014 – Silverado, a provider of memory care, ... it is a Bronze winner in the 35th Annual Telly ... a Child's Eye and Silverado Resident Visits Space ... Child's Eye , seven-year-old Mia Sandoval shares her experience coming ... memory care community in Los Angeles. The feel-good video highlights ...
Breaking Medicine News(10 mins):Health News:Bacteria resistant materials -- £2m to get the 'inside' story 2Health News:Bacteria resistant materials -- £2m to get the 'inside' story 3Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 2Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 3Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 4Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3Health News:Research may explain how foremost anticancer 'guardian' protein learned to switch sides 2Health News:Silverado Selected a Winner in the 35th Annual Telly Awards for Producing Inspiring Online Video Content 2
... people suffering from diabetes is already over 194 million ... 333 million by 2025. Type II diabetes is also ... by a relative disparity between endogenous insulin production and ... to Type I diabetes, there is always some endogenous ...
... cases has reached about 1.2 million worldwide and Statistics show ... urban India and has overtaken cancer of the cervix as ... according to a study conducted on women and cancer in ... motherhood are some factors that can lead to a high ...
... antibiotics may be used to treat childhood cholera. ... children can be treated effectively with a single dose ... study published online by The Lancet., ,Cholera is ... areas in less-developed countries. In the resource-limited countries where ...
... Professor Alice Sigurdson and Colleagues has reported the dosage ... which increases the risk of thyroid cancer. ... were treated for thyroid cancer during their childhood. The ... risk of developing thyroid cancer and there seems to ...
... less at risk from developing the dreaded disease of ... recent issue of Archives of Neurology. ,In previous ... course of a MS-like disease in animals, suggesting that ... postpartum period afterward, both states associated with profound hormonal ...
... children who survive cancer have about twice the rate ... a history of cancer. The study finds children ... children treated with cranial radiation therapy (CRT) are at ... ,As therapies for childhood cancers have become more ...
Cached Medicine News:Health News:Sitagliptin, Under Investigation For Type 2 Diabetes 2Health News:Risk of Thyroid cancer is increased after Childhood Irradiation of Neck region 2Health News:Socialization A Serious Trouble For Childhood Cancer Survivors 2
Multi-constituent normal and abnormal plasma controls for routine and specialty assays performed on the STA© family of hemostasis analyzers....
PT, PTT, Fibrinogetn & TT Normal and Abnormal Controls...
Fructosamine Calibrator...
ApolipoproteinA-1 & B Calibrator...
Medicine Products: